{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Healthy+Control&page=8", "query": { "intervention": "Healthy Control", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 5543, "total_pages": 555, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Healthy+Control&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Healthy+Control&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T07:32:26.544Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02069366", "title": "Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Traumatic Stress Disorder" ], "interventions": [ { "name": "Dronabinol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "21 Years to 45 Years" }, "enrollment_count": 86, "start_date": "2014-11", "completion_date": "2019-12", "has_results": true, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02069366" }, { "nct_id": "NCT06469151", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "AZD5148", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 84, "start_date": "2024-06-24", "completion_date": "2025-10-22", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 4, "location_summary": "Anniston, Alabama • Glendale, California • Baltimore, Maryland + 1 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06469151" }, { "nct_id": "NCT04124029", "title": "Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mild Traumatic Brain Injury", "Moderate Traumatic Brain Injury", "Mild Cognitive Impairment" ], "interventions": [ { "name": "No Intervention is used for this study but all subjects will be asked to complete electroencephalogram (EEG) testing and an MRI scan.", "type": "DEVICE" }, { "name": "No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure.", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "30 Years to 90 Years" }, "enrollment_count": 800, "start_date": "2021-07-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04124029" }, { "nct_id": "NCT00345579", "title": "Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b", "Neisseria Meningitidis" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pediarix/Infanrix Penta", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4432, "start_date": "2006-09", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00345579" }, { "nct_id": "NCT05918627", "title": "A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Immune System Disorder (Healthy Volunteer)" ], "interventions": [ { "name": "Belumosudil mesylate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kadmon, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2009-09-21", "completion_date": "2009-12-09", "has_results": false, "last_update_posted_date": "2023-06-26", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05918627" }, { "nct_id": "NCT01938742", "title": "H7N9 Mix and Match With MF59 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013", "type": "BIOLOGICAL" }, { "name": "MF59", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "19 Years to 64 Years" }, "enrollment_count": 700, "start_date": "2013-09", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2016-12-12", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 4, "location_summary": "Decatur, Georgia • Iowa City, Iowa • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Decatur", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01938742" }, { "nct_id": "NCT06420141", "title": "The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neuropathic Pain" ], "interventions": [], "intervention_types": [], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 250, "start_date": "2024-01-03", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06420141" }, { "nct_id": "NCT03916237", "title": "Registry and Screening Tool to Identify Children With Asthma Likely to Benefit From Home Assessment and Remediation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma", "Pediatric ALL", "School Health Services", "Registries", "Medical Informatics", "Home Visits", "Housing Problems", "Social Determinants of Health", "Healthcare Disparity", "Health Status Disparity" ], "interventions": [ { "name": "Home assessment", "type": "OTHER" }, { "name": "Home remediation", "type": "OTHER" }, { "name": "Referral to Medical Legal Partnership", "type": "OTHER" }, { "name": "Regular School Based Health Asthma Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "MetroHealth Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 21, "start_date": "2019-12-01", "completion_date": "2023-06-01", "has_results": false, "last_update_posted_date": "2023-10-19", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03916237" }, { "nct_id": "NCT05298254", "title": "A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Herpes Simplex" ], "interventions": [ { "name": "Non-adjuvanted HSV formulation 1", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 2", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 3", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "HSVTI_F1", "type": "BIOLOGICAL" }, { "name": "HSVTI_F2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 505, "start_date": "2022-03-07", "completion_date": "2025-06-12", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Wichita, Kansas • Kansas City, Missouri + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Rochester", "state": "New York" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05298254" }, { "nct_id": "NCT01404754", "title": "Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psychological Effects of Study Drug" ], "interventions": [ { "name": "Lactose (inactive placebo)", "type": "DRUG" }, { "name": "midomafetamine HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Resilient Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 107, "start_date": "2011-04-09", "completion_date": "2022-08-05", "has_results": false, "last_update_posted_date": "2024-10-31", "last_synced_at": "2026-10-19T07:32:26.544Z", "location_count": 3, "location_summary": "Boulder, Colorado • Santa Fe, New Mexico • Mt. Pleasant, South Carolina", "locations": [ { "city": "Boulder", "state": "Colorado" }, { "city": "Santa Fe", "state": "New Mexico" }, { "city": "Mt. Pleasant", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01404754" } ] }